Summary: Glycohaemoglobin in human blood can be determined by several methods. We investigated three methods used in daily practice, viz. affinity chromatography, HPLC and electrophoresis* We examined the influence of uraemia in diabetic and non-diabetic patients on the results obtained with HPLC and electrophoresis and compared these with the results obtained with affinity chromatography. Our current method (electrophoresis) proved to be very sensitive to uraemia giving falsely elevated levels of HbAj. HPLC was not disturbed by uraemia.
Introduction
During the last decade the measurement of glycohaemoglobin has proven to be a useful tool in glycaemic control (1) . Glycohaemoglobin is formed by a non-enzyjriatic reaction between glucpse or other carbohydrates and haemoglobin. For example, the main haemoglobin, HbA 0 , is glycated at the N-^tenninal valine (a-chain 14%, ß-chairi 60%) or at an -lysine residue (a-ohain 40%, ß-chain 46%) to form HbA^, HbAi a2 , HbA lb and HbA lc respectively. Tpgether these compounds are known äs HbAi (1) .
Glycohaemoglobin in blood is commonly determined by HPLC, electrophoresis or affinity chromatography (2) (3) (4) .
In the HPLC method, different haemoglobins are bpund to a cation-exchange column, and the HbA^ fraction is quantitated. Affinity chromatography is based on the binding of all glycated haemoglobins to phenylboronate coupled to agarose.
Electrophoresis separates HbAi from other haemoglobins by electroendosmosis.
Unfortunately, interference by alcohol, acetaldehyde, lipaemia and uraemia is very common (3) (4) (5) . Uraemia is particularly common in diabetes. Interference from uraemia can be explained by carbamylation of haemoglobin. This carbamylated haemoglobin comigrates with HbA lc in HPLC and electrophoresis thus leading to an overestirnation of the result (6-7).
Uraemia has been reported äs an interfering factor in HPLC results from diabetic population (8) . Recently, Tsang et al. reported that the Ciba Corning electroendosmosis is not affected by uraemia (plasma urea > 25 mmol/1) in diabetic patients (9) . Since affinity chromatography is based essentially on binding of the carbohydrate moiety of the protein to the resin, this technique is theoretically not affected by carbamylation (2) . In this study we investigated the influence of uraemia on the results obtained by HPLC and electrophoresis, compared with the results obtained with affinity chromatography.
Materials and Methods

Sampies
Blood was drawn in 5 ml EDTA tubes. After centrifugation at 3000 g for 10 min, plasma was removed and used for urca detenniEur. J. Clin. Chem. Clin. Biochem. / Vol. 32. 1994 / No. 5 nation. Red blood cells vvere washed with 9 g/l NaCl and used for measurement of HbA b total glycated Hb and HbAi c .
Electrophoresis
After nn overnight incubation in 9 g/l NaCl, cells were sedimented by centrifiigation (10 min, 4000g) and 100 μΐ of pelleted cells vvere added to 800 μΐ of water. The haemolysate was kept overnight at -20 °C, then 0.8 μΐ was spotted on agar gels (Ciba Corning Diagnostics N. V., Houten, NL). After electrophoresis in "glycohaemoglobin buffer" pH 6.3 (Ciba Corning Diagnostics N. V., Houten, NL), gels vvere stained with Amido Black and scanned with a Cliniscan densitometer (Helena Laboratories, Gateshead, UK).
Affinity chromatography
An aliquot of pelleted cells (50 μΐ) was added to l ml of glycohaemolysis II (Instruchemie Hilversum B. V., NL). After centrirugation at 3000 g for 5 min, 50 μΐ of the haemolysate were placed on a Glyco.gel II column (Pierce Chemical Company, USA) and eluted s described by the manufacturer.
Patient selection
To determine the interference by urea, the following patient groups were selected: healthy volunteers, non-di betic, non-uraemic, age 20->60 (group l, n = 24); non-diabetic, uraemic patients receiving haemodialysis, age 34-79 (group 2, n = 20); diabetic, non-uraemic patients, age 17-76 (group 3, n = 25) and diabetic, uraemic patients receiving haemodialysis, age 35-71 (group 4, n = 16).
Non-uraemic patients had blood urea concentrations between 3 and 7 mmol/l. Blood urea concentrations in uraemic patients were > 18 mmol/1 for at least three rhonths preceding this investigation. The mean urea concentration of group 2 patients was 29.4 mmol/1, and of group 4 patients 28.5 rnmol/1.
Statistics
We used Studenfs t-test (unpaired data) fqr determining the significance of the influence of uraemia on the various methods.
High performance liquid chromatography EDTA-blood (0.6 ml) was mixed with 10 ml 9 g/l saline and incubated for 4 hours at 37 °C. Cells were sedimented by centrifugation at 3000 £ for 5 min. Water (2.5 ml) and CC1 4 (0.5 ml) were added to resulting pellet of red cells, and the mixture vigorously shaken for 2 min. After centrifugation, 70 μΐ of the haemolysate were added to 700 μΐ of "sample buffer". Samples were placed on a Mono-S HR5/5 column and eluted using a salt gradient (0-0.3 mol/1 NaCl) in 0.01 mol/1 malonic acid pH 5.7. This procedure separates HbF from HbA lc (Pharmacia, Uppsala, Sweden).
Urea was measured with urease (Boehringer Mannheim GmbH, Germany) on a Hitachi 717 (Hitachi Ltd. Tokyo, Japan).
Within-run precision
Two pools of haemolysate were prepared for each method and measured 14 times in the same run.
The coefficients of Variation for electrophoresis (5-9%) were two to three times higher than for the other method.
Between-run precision
Two control sera from Instruchemie (Glycohemonorm and cohemopath) were used for HPLC and affmity chromatography. Two haemolysates of Ciba Corning (high HbAj and low HbAj) were used for electrophoresis. The controls were measured 10 times during a period of 3 months.
The coefficients of Variation for electrophpresis (10-12%) were two to three times higher than for the other methods.
Accuracy
Freeze dried haemolysates, which are routinely used for exterhal quality control in hospital laboratories in the Netherlands, were obtained from the SKZL (Dutch Foundation for Quality Assessment in Clinical Chemistry). Values were compared with the average values obtained by all participants using the sarne method.
In all three methods our values ranged between the highest and lowest value found by all participants.
Results
Interference in HPLC and electrophoresis by uraemia was investigated using the 3 groups of patients and pne group of healthy volunteers. The results are shown in table 1.
We assumed that the results of glycohaemoglobin measurements by affmity chromatography would not be disturbed by excessive amounts of carbamyl ted haemoglobin. The hypothesis that HbAi (C ) measurements by HPLC and electrophoresis are unreliable when uraemia is present was tested by determining the differences between the three methods in four groups of subjects s described in Materials and Methods. We calculated the differences between the values for affinity chromatography (A) and HPLC (H), or affinity chromatography and electrophoresis (E) for all persons in each group (ΔΗΑ and ΔΕΑ). Next we used Studenfs t-test for unpaired data to compare ΔΗΑ and ΔΕΑ of uraemic and nonuraemic subjects. A significant difference was found between affinity chromatography and electrophoresis, but not between affinity chromatography and HPLC.
These findings are in accord with the relation between the urea concentration and the results of glycohaemoglo* bin measurements in group l volunteers and group 2 uraemic patients s shown in figure l. Affinity chromat ography gives essentially the same results in both groups, whereas electrophoresis gives considerably higher results in the uraemic group. The same phenomê non is harder to assess in diabetic patients, bec tise of the higher glycohaemoglobin values and the wide r nge of results in these groups.
The values for glycated haemoglobins in group l volunteers ( fig. 1) Tab. l Interference of carbamylated haemoglobin with the measurement of glycohaemoglobin using three different methods, one group of heallhy volunteers and three groups of patients. ΔΗΑ: diffcrencc between HPLC and affinity chromatography in each group: ΔΕΑ: difference between electrophoresis and affinity chromatography in each group.
The difference in ΔΗΑ between group l and 2 is not significant (p > 0.05) whereas the difference in ΔΕΑ is (p < 0.001). The difference in ΔΗΑ between group 3 and 4 is not significant (p > 0.05), whereas the difference in ΔΕΑ is (p < 0.001). ments. On theoretical grounds, we assumed that results frorn affinity chromatography would not be influenced by carbamylated haemoglobins (2) . We compared affinity chromatography with HPLC and electrophoresis. HPLC did not show a significant difference between uraemic and non-uraemic groups of patients, whereas electrophoresis did.
Group 1 Healthy
Group 2 Uraemic
Clearly our results do not confirm those of Engbaek et al. (8) , who found a significant interference by carbamylated haemoglobin in HPLC, and those of Tsang et al., who found no significant difference between uraemic and non-uraemic patients in the diabetic group using electrophoresis. Their strategies," however, were somewhat different from ours. Engbaek et al. (8) used in vitro carbamylated haemoglobin and found higher glycohaemoglobin values with HPLC than with an enzyme immunoassay (EIA). They also compared diabetic patients with normal and near normal renal function with patients with chronic renal failure. One might argue that carbamylation in vitro does not reflect the Situation in vivo where haemoglobin can be carbamylated or glycated at different rates, depending on the concentrations of the substituents.
Tsang et al. (9) used 169 patients with varying degrees of diabetes and renal failure. They supposed that all subgroups with a comparable blood glucose concentration would automatically have the same level of HbA t . We argue that such patient groups might be thought erroneously to have the same level of glycohaemoglobin, when measured by electrophoresis, especially when these groups are smalL Significant differences will not be found because of the large r nge of expected values. Notably group 3 and 4 in our study had the same HbAj level using electrophoresis, but had significantly differ-ent levels of glycohaemoglobin äs measured with affinity chromatography (8.8 vs 7.2% p < 0.01). In our study, the HPLC results show no significant differences from the affmity chromatography results for diabetic patients with (7.2 vs 7.7% p > 0.05) and without (8.8 vs 8.9% p > 0.05) uraemia. Our results confirm that carbamylated haemoglobin comigrates with glycohaemoglobin in electrophoresis. In contrast, and unexpectedly, the ineasurement of HbAj by HPLC was not disturbed by the preserice of uraemia, and can therefore be used for monitoring the glycaemia fo diabetic patients with uraemia.
